Considering that only the ACE and AT2R1 genes were prognostically significant for cognitive impairment development in patients with CTE, Model 3 included only these genes along with the previously mentioned cofactors: patient sex, age category, disease duration, and comorbidities. The gene discussed is ACE; the disease is Cognitive impairment.